Story perspectives

China Approves First Invasive Brain-Computer Interface Device

3/29/2026

Summary

Story summary

Neuracle Medical Technology (Shanghai-based) received approval from the National Medical Products Administration for its implantable brain-computer interface, Neural Electronic Opportunity (Neo), the first invasive BCI device available outside clinical trials.
The BCI field balances non-invasive methods, which lack precision, against invasive methods, which pose safety risks.
This milestone shows China has surpassed the United States in invasive BCI commercialization.
The development underscores China's growing leadership in BCI research and commercialization.

1 of 1

Story summary

Neuracle Medical Technology (Shanghai-based) received approval from the National Medical Products Administration for its implantable brain-computer interface, Neural Electronic Opportunity (Neo), the first invasive BCI device available outside clinical trials.
The BCI field balances non-invasive methods, which lack precision, against invasive methods, which pose safety risks.
This milestone shows China has surpassed the United States in invasive BCI commercialization.
The development underscores China's growing leadership in BCI research and commercialization.